Clinical trial
A Canadian Retrospective Analysis of Persistence on Ofatumumab Using Patient Support Program Data
NCT06854341 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Canadian Retrospective Analysis of Persistence on Ofatumumab Using Patient Support Program Data
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 9, 2024
- Completion date
- August 27, 2024
- Enrollment
- 5,448 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.